Skip to main content
. 2020 Aug 19;149(2):273–282. doi: 10.1007/s11060-020-03595-5

Table 4.

Crude and age-adjusted incidence rates of brain/CNS tumors by sex, according to histology group, for Zurich (Switzerland), March 1, 2009 to February 29, 2012

Group Specific histology WHO histology code N % CIR AIR (95% CI) Females Males
N % CIR AIR (95% CI) N % CIR AIR (95% CI)
Neuroepithelial 377 34.1 9.23 8.37 (7.52, 9.29) 148 23.3 7.16 6.49 (5.45, 7.68) 229 48.7 11.35 10.57 (9.22, 12.07)
Pilocytic astrocytoma 9421 13 1.2 0.32 0.43 (0.23, 0.73) 4 0.6 0.19 0.27 (0.07, 0.66) 9 1.9 0.45 0.59 (0.27, 1.10)
Diffuse astrocytoma 9400, 9411, 9420 17 1.5 0.42 0.37 (0.21, 0.60) 7 1.1 0.34 0.34 (0.13, 0.71) 10 2.1 0.50 0.42 (0.20, 0.79)
Anaplastic astrocytoma 9401 25 2.3 0.61 0.58 (0.37, 0.86) 10 1.6 0.48 0.47 (0.22, 0.87) 15 3.2 0.74 0.70 (0.39, 1.17)
Glioblastoma 9440, 9441, 9442/3 216 19.6 5.29 4.32 (3.76, 4.95) 83 13.1 4.02 3.20 (2.53, 3.99) 133 28.3 6.59 5.69 (4.76, 6.77)
Other astrocytomas 9380, 9381, 9384, 9424, 9425 19 1.7 0.47 0.44 (0.26, 0.70) 10 1.6 0.48 0.50 (0.22, 0.94) 9 1.9 0.45 0.42 (0.19, 0.81)
Oligodendroglioma 9450 5 0.5 0.12 0.11 (0.03, 0.26) 2 0.3 0.10 0.09 (0.01, 0.34) 3 0.6 0.15 0.12 (0.02, 0.39)
Anaplastic oligodendroglioma 9451 7 0.6 0.17 0.15 (0.06, 0.31) 3 0.5 0.15 0.13 (0.03, 0.40) 4 0.9 0.20 0.17 (0.05, 0.46)
Oligoastrocytoma 9382 9 0.8 0.22 0.20 (0.09, 0.38) 4 0.6 0.19 0.17 (0.05, 0.45) 5 1.1 0.25 0.22 (0.07, 0.53)
Ependymoma 9383, 9391, 9392, 9394 39 3.5 0.95 0.96 (0.68, 1.32) 12 1.9 0.58 0.63 (0.32, 1.11) 27 5.7 1.34 1.31 (0.86, 1.92)
Neuronal—glial 8680, 9390, 9413, 9492, 9493, 9505, 9506 14 1.3 0.34 0.40 (0.21, 0.67) 7 1.1 0.34 0.32 (0.13, 0.68) 7 1.5 0.35 0.46 (0.18, 0.92)
Embryonal—medulloblastoma 9470, 9471, 9473, 9508 13 1.2 0.32 0.42 (0.22, 0.72) 6 0.9 0.29 0.38 (0.13, 0.81) 7 1.5 0.35 0.46 (0.19, 0.93)
Tumours of cranial and spinal nerves Neurinoma 9560 118 10.7 2.89 2.50 (2.06, 3.00) 61 9.6 2.95 2.51 (1.91, 3.24) 57 12.1 2.82 2.45 (1.85, 3.19)
Tumours of meninges 449 40.7 10.99 9.04 (8.22, 9.93) 346 54.6 16.75 13.02 (11.66, 14.51) 103 21.9 5.10 4.45 (3.63, 5.42)
Meningioma 9530, 9531, 9532, 9533, 9534, 9537, 9538, 9539 435 39.4 10.65 8.71 (7.90, 9.58) 340 53.6 16.46 12.72 (11.38, 14.19) 95 20.2 4.71 4.06 (3.28, 4.98)
Mesenchymal—lipoma, haemangioma 8815, 8850, 8861, 9120, 9133, 9150, 9180, 9220, 9364 3 0.3 0.07 0.07 (0.01, 0.21) 2 0.3 0.10 0.10 (0.01, 0.36) 1 0.2 0.05 0.05 (0.00, 0.27)
Haemangioblastoma 9161 11 1.0 0.27 0.26 (0.13, 0.48) 4 0.6 0.19 0.20 (0.05, 0.52) 7 1.5 0.35 0.34 (0.14, 0.72)
Lymphomas Lymphoma 9590, 9680 18 1.6 0.44 0.37 (0.22, 0.59) 7 1.1 0.34 0.31 (0.12, 0.65) 11 2.3 0.55 0.49 (0.24, 0.89)
Germ cell Germinoma 9064, 9080, 9084, 5 0.5 0.12 0.13 (0.04, 0.31) 1 0.2 0.05 0.04 (0.00, 0.26) 4 0.9 0.20 0.22 (0.06, 0.55)
Tumours of the sellar region 92 8.3 2.25 1.92 (1.54, 2.36) 44 6.9 2.13 1.80 (1.30, 2.44) 48 10.2 2.38 2.11 (1.55, 2.81)
Pituitary adenoma 8271, 8272 92 8.3 2.25 1.92 (1.54, 2.36) 44 6.9 2.13 1.80 (1.30, 2.44) 48 10.2 2.38 2.11 (1.55, 2.81)
Craniopharyngioma 9350 0 0 0 0 0 0 0 0 0 0 0 0
Unclassified Unclassified 8000 45 4.1 1.10 0.96 (0.69, 1.30) 27 4.3 1.31 1.10 (0.70, 1.64) 18 3.8 0.89 0.83 (0.49, 1.33)
Total 1104 100 27.03 23.29 (21.91, 24.73) 634 100 30.69 25.27 (23.29, 27.39) 470 100 23.29 21.12 (19.22, 23.16)

AIR age-adjusted incidence rate per 100,000 person-years (adjusted to the US 2000 standard population), 95% CI 95% confidence intervals (based on the gamma distribution proposed by Tiwari et al. [17]), CIR crude incidence rate